Clinical Trial Update: Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix

View source ↗

Summary

A completed clinical trial evaluating cisplatin plus a one-day, 24-hour infusion of high-dose 5-fluorouracil for stage IVB, recurrent or metastatic cervical can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Cervical Cancer | Status: COMPLETED